Stool Transplants Highly Efficient For Clostridium difficile Infections And Other Gastrointestinal Conditions
Faecal microbiota transplantation offers a rapidly acting and highly effective alternative in treating recurrent Clostridium difficile infections (RCDI), as Professor Lawrence J. Brandt (Montefiore Medical Center, New York, USA) points out. According to him, more than 90 per cent of the patients are being cured within a short period of time. Further information on this issue - one of many topics presented at the 2nd World Summit "Gut Microbiota For Health" in Madrid, Spain - can be found here.
To keep themselves up to date on the rapidly increasing advances in the field of gut microbiota research, scientists and health-care professionals came together at the 2nd Gut Microbiota For Health World Summit. This year, the event was hosted by the Gut Microbiota & Health Section of the European Society of Neurogastroenterology and Motility (ESNM) - a member of United European Gastroenterology (UEG) - and the American Gastroenterological Association (AGA), with the support of Danone Dairy.
Visit our GastroIntestinal / Gastroenterology category page for the latest news on this subject, or sign up to our newsletter to receive the latest updates on GastroIntestinal / Gastroenterology.
Please use one of the following formats to cite this article in your essay, paper or report:
American Gastroenterological Association. "Stool Transplants Highly Efficient For Clostridium difficile Infections And Other Gastrointestinal Conditions." Medical News Today. MediLexicon, Intl., 28 Feb. 2013. Web.
12 Feb. 2016. <http://www.medicalnewstoday.com/releases/256933.php>
American Gastroenterological Association. (2013, February 28). "Stool Transplants Highly Efficient For Clostridium difficile Infections And Other Gastrointestinal Conditions." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.